For people taking GLP-1 agonist medications who are getting ready for a colonoscopy, its important to let the GI team know about this
Always let the prescribing doctor know, so they have the full picture and can adjust treatment if needed
Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist that was originally developed for type 2 diabetes management and subsequently approved by the FDA for chronic weight management under the brand name Wegovy
L-Carnitine, a key ingredient in Monster Energy Ultra Gold, plays a vital role in energy metabolism
Because immune benefits are systemic rather than visible, results are often felt before they are measured
Improvements in glycaemic control, blood pressure, and lipid parameters were also observed